These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7830104)

  • 1. Pefloxacin in the treatment of severe infections in gynecological cancer patients.
    Scalambrino S; Colombo M; Negri L; Maggioni A; Milani R
    J Chemother; 1994 Aug; 6(4):257-64. PubMed ID: 7830104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New possibilities in the care of surgical infections (personal experience with pefloxacin)].
    Rakovec S; Stanisavljević D
    Acta Chir Iugosl; 1989; 36 Suppl 2():748-50. PubMed ID: 2618497
    [No Abstract]   [Full Text] [Related]  

  • 3. Pefloxacin efficacy in gram-negative bacillary meningitis.
    Segev S; Rosen N; Joseph G; Elran HA; Rubinstein E
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():187-92. PubMed ID: 2258348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pefloxacin in the antibacterial treatment of immunodepressed patients.
    Cajozzo A; Carbone R; Carotenuto M; Grana M; La Sala A; Mancuso S; Perricone R; Sgalambro A; Dammacco F
    J Chemother; 1990 Jun; 2(3):185-9. PubMed ID: 2199629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pefloxacin in the treatment of septicemia, purulent meningitis and salmonellosis].
    Dordević D; Kaplan M; Cengić D; Vranić B; Dimitrijević K
    Med Arh; 1989; 43(4-6):207-10. PubMed ID: 2640275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
    Giustina A; Romanelli G; Cravarezza P; Ravizzola G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):668-9. PubMed ID: 16312584
    [No Abstract]   [Full Text] [Related]  

  • 11. Pefloxacin treatment of meningitis caused by gram-negative bacteria.
    Segev S; Barzilai A; Rosen N; Joseph G; Rubinstein E
    Arch Intern Med; 1989 Jun; 149(6):1314-6. PubMed ID: 2730249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():173-80. PubMed ID: 2258346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of infectious complications of major upper respiratory and digestive tract surgery by the combination of pefloxacin-amoxicillin-clavulanic acid].
    Russier M; Mirault F; Champroux T; Leclercq I; Gaillard de Collogny L; Lafaye M
    Ann Otolaryngol Chir Cervicofac; 1990; 107(6):406-10. PubMed ID: 2256615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections.
    Vanderdonckt J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():111-6. PubMed ID: 2258338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations with Péflacine.
    Ludwig E; Székely E; Arr M
    Ther Hung; 1993; 41(4):128-31. PubMed ID: 8029779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pefloxacin in the treatment of CAPD peritonitis.
    Tan HW; Kon SP; Chua CT; Ngeow NF
    Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pefloxacin in the treatment of gram-negative infections in patients with hematologic diseases.
    Micozzi A; Martino P; Raccah R; Girmenia C; Gentile G; Santilli S; Monarca B
    Haematologica; 1989; 74(6):583-5. PubMed ID: 2628241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
    Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical pefloxacin in bacterial keratitis.
    Vajpayee RB; Sharma N; Verma B; Vajpayee M; Gupta SK; Satpathy G; Saxena R
    Int Ophthalmol; 1998; 22(1):47-51. PubMed ID: 10090449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic bone infections after surgery. Treatment with the new quinolones].
    Bricaire F; Godeau B; Salmon D; Karam D; Leport C; Vildé JL
    Presse Med; 1989 Sep; 18(28):1383-6. PubMed ID: 2529506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.